Germline Incorporation of a Replication-Defective Adenoviral Vector in Mice Does Not Alter Immune Responses to Adenoviral Vectors
Open Access
- 1 November 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 2 (5) , 496-504
- https://doi.org/10.1006/mthe.2000.0199
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cyclosporine induces cancer progression by a cell-autonomous mechanismNature, 1999
- Evaluating the Potential of Germ Line Transmission after Intravenous Administration of Recombinant Adenovirus in the C3H MouseHuman Gene Therapy, 1998
- An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis.Journal of Clinical Investigation, 1998
- A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.Proceedings of the National Academy of Sciences, 1996
- Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia.Journal of Clinical Investigation, 1995
- Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX ExpressionHuman Gene Therapy, 1995
- Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.Proceedings of the National Academy of Sciences, 1995
- Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries.Circulation, 1994
- Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.Proceedings of the National Academy of Sciences, 1994
- Negative selection of lymphocytesCell, 1994